Contraindicated. Coadministration of doravirine with a powerful CYP3A inducer may well reduce doravirine plasma concentrations and/or effects. Opportunity for lack of virologic reaction and possible resistance to doravirine.pentobarbital will minimize the extent or influence of armodafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. M